Omega Healthcare Investors OHI Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 51.1%+9.8pp | 49.6%+10.9pp | 46.8%+12.9pp | 42.2%+9.0pp | 41.3%+13.3pp | |
| EBITDA margin | 98%+6.8pp | 97.9%+7.8pp | 96.6%+8.5pp | 91.8%+1.3pp | 91.2%+5.0pp | |
| Free cash flow margin | 68.2%+1.0pp | 67%-0.7pp | 70.2%+6.1pp | 69.8%+5.1pp | 67.2%+3.8pp | |
| Returns | ||||||
| Return on equity | 12.7%+1.9pp | 12.1%+2.1pp | 11.7%+2.9pp | 10.8%+2.0pp | 10.9%+3.1pp | |
| Return on assets | 6.3%+1.6pp | 5.9%+1.6pp | 5.3%+1.7pp | 4.9%+1.3pp | 4.8%+1.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Interest coverage | 4.2×+1.0× | 3.9×+1.0× | 3.6×+1.0× | 3.3×+0.8× | 3.1×+0.9× | |
| Valuation | ||||||
| Market capitalization | $12.95B+20.7% | $13.1B+28.2% | $12.45B+22.7% | $10.74B+27.4% | $10.73B+37.7% | |
| Price / earnings | 20.5×-3.5× | 22.2×-2.9× | 23.1×-6.5× | 22.8×-3.1× | 24×-4.6× | |
| Price / sales | 10.5×+0.6× | 11×+1.3× | 10.8×+0.8× | 9.6×+1.0× | 9.9×+1.9× | |
| Price / book | 2.5×+0.2× | 2.5×+0.3× | 2.5×+0.1× | 2.2×-0.1× | 2.3×0.0× | |
| Free cash flow yield | 6.5%-0.3pp | 6.1%-0.9pp | 6.5%+0.1pp | 7.2%-0.3pp | 6.8%-1.1pp | |
| Earnings yield | 4.9%+0.7pp | 4.5%+0.5pp | 4.3%+0.9pp | 4.4%+0.5pp | 4.2%+0.7pp | |
| Dividend yield | 6.1%-0.5pp | 6%-0.8pp | 6.1%-0.5pp | 6.9%-1.0pp | 6.6%-1.7pp | |
| PEG ratio | 0.5×+0.1× | 0.5×— | 0.4×— | 0.5×— | 0.4×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Omega Healthcare Investors's ratios come from?
- Every ratio is computed from Omega Healthcare Investors's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
